- Home
- ยป
- Our Products
- »
- Pharmaceutical Tablets - 2
Pharmaceutical Tablets - 2
Valgan Valganciclovir 450 Mg
Product Brochure
| Packaging Size | 1*4 Tablets |
| Dose/Strength | 450 mg |
| Pack size | 4 Tablet |
| Composition (salt) | Valganciclovir 450 mg |
| Brand Name | Valgan 450 mg |
| Manufactured By | Cipla Ltd |
| Usage/Application | Cytomegalovirus Infection |
Overview
Valgan contains valganciclovir, an antiviral medication used primarily for the prevention and treatment of cytomegalovirus (CMV) infections, particularly in immunocompromised patients.
- CMV Retinitis: Used in patients with acquired immunodeficiency syndrome (AIDS) who have CMV retinitis.
- Prevention of CMV Infection: Used for the prevention of CMV disease in kidney transplant recipients and other high-risk patients.
Valganciclovir is a prodrug that is converted in the body to ganciclovir, which works by:
- Inhibiting Viral DNA Synthesis: It interferes with the replication of viral DNA, thereby inhibiting the growth of the virus.
- Dosage: The typical dose for treating CMV retinitis in adults is 900 mg taken twice daily for 21 days, followed by 900 mg once daily for maintenance. For prevention in transplant patients, the usual dose is 900 mg once daily.
- Administration: Tablets should be taken orally with food to enhance absorption. Ensure adequate hydration.
Common side effects may include:
- Diarrhea
- Nausea
- Vomiting
- Fatigue
- Bone marrow suppression (leading to anemia, leukopenia, or thrombocytopenia)
- Hematologic Effects: Regular monitoring of blood counts is essential due to the risk of bone marrow suppression.
- Renal Function: Monitor renal function, as valganciclovir is eliminated primarily through the kidneys.
- Teratogenic Effects: Valganciclovir can cause birth defects; effective contraception is crucial for both men and women during treatment.
- Hypersensitivity: Known allergies to valganciclovir, ganciclovir, or any components of the formulation.
- Severe Bone Marrow Suppression: Contraindicated in patients with a history of severe neutropenia or thrombocytopenia.
Valganciclovir may interact with:
- Other Antivirals: Caution is advised when used with other medications that may also cause bone marrow suppression.
- Renal Drugs: Medications that affect renal function may alter the clearance of valganciclovir.
- Store Valgan at room temperature, away from moisture and light. Keep out of reach of children.
- Educate patients on the importance of adhering to the prescribed regimen and the necessity of regular blood monitoring.
- Advise them to report any signs of infection, unusual bleeding, or other severe side effects immediately.
Valgan (Valganciclovir 450 mg Tablets) is an important antiviral medication for managing and preventing CMV infections, particularly in high-risk populations. Proper administration, monitoring for side effects, and patient education are vital for effective treatment outcomes. Always consult a healthcare provider for personalized advice and guidance.
Alpha Ketoanalogue Ketosteril Tablet
Product Brochure
| Packaging Size | 5*20 Tablets |
| Pack Size | 10 Tablet |
| Composition | Alpha Ketoanalogue (NA) |
| Brand Name | Ketosteril Tablet |
| Manufacturer | Fresenius Kabi India Pvt Ltd |
| Treatment | Chronic kidney disease |
Overview
Ketosteril is a dietary supplement that contains a combination of alpha-keto acids, which are used to manage patients with chronic kidney disease (CKD), particularly those on a protein-restricted diet.
- Chronic Kidney Disease: Used as a supplement in patients with CKD to help manage protein intake while ensuring adequate nutrition and minimizing nitrogenous waste buildup.
Alpha-keto acids are precursors to essential amino acids and can help:
- Reduce Protein Catabolism: They provide a non-protein source of nitrogen for amino acid synthesis, helping to maintain protein balance without increasing urea levels.
- Dosage: The typical dosage is determined by a healthcare provider based on individual dietary needs and renal function. It is generally taken with meals to enhance absorption.
- Administration: Tablets should be taken orally, as directed by a healthcare professional.
Common side effects may include:
- Gastrointestinal disturbances (nausea, diarrhea)
- Allergic reactions (rare)
- Monitoring: Regular monitoring of renal function and nutritional status is essential to adjust dosages and dietary intake as needed.
- Dietary Adjustments: Patients should follow a protein-restricted diet as advised by their healthcare provider to maximize the benefits of Ketosteril.
- Hypersensitivity: Known allergies to any components of the formulation.
- Acute Kidney Injury: Not recommended in patients with acute renal failure.
Ketosteril generally has a low potential for drug interactions, but it's always important to inform healthcare providers about all medications and supplements being taken.
Storage Instructions- Store Ketosteril at room temperature, away from moisture and light. Keep out of reach of children.
- Educate patients on the importance of adhering to their prescribed dietary restrictions and the role of Ketosteril in their overall management.
- Advise them to report any unusual symptoms, particularly gastrointestinal issues or allergic reactions.
Ketosteril (Alpha Ketoanalogue Tablets) is a useful dietary supplement for managing chronic kidney disease by providing essential amino acids without increasing protein intake. Proper usage, monitoring, and patient education are key to achieving effective outcomes. Always consult a healthcare provider for personalized advice and guidance.
Nirmatrelvir Tablets 150 Mg & Ritonavir Tablets IP 100 Mg Combipack ( Paxista)
Product Brochure
| Strength | 150 mg + 100 mg |
| Pack Size | 30 tablets |
| Brand | Paxista 150mg/100mg |
| Manufacturer | Azista |
| Packaging Size | 2 Blisters of Nirmatrelvir, 1 Blister of Ritonavir |
| Composition | Nirmatrelvir (150mg) + Ritonavir (100mg) |
| Usage/Application | Treatment of Coronavirus disease (COVID-19) |
Overview
Paxista is a combination pack containing nirmatrelvir and ritonavir, indicated for the treatment of mild to moderate COVID-19 in patients at high risk of developing severe illness.
- COVID-19 Treatment: Specifically for the treatment of COVID-19 in adults and pediatric patients (12 years and older weighing at least 40 kg) who are at high risk for progression to severe disease.
- Nirmatrelvir: An antiviral medication that inhibits the replication of SARS-CoV-2, the virus responsible for COVID-19.
- Ritonavir: A protease inhibitor that enhances the effectiveness of nirmatrelvir by inhibiting enzymes that break down the antiviral, thereby increasing its levels in the body.
- Nirmatrelvir works by inhibiting the viral protease, which is essential for viral replication.
- Ritonavir acts to boost the plasma concentration of nirmatrelvir, allowing for more effective viral suppression.
- Dosage: The typical regimen is two tablets of nirmatrelvir (150 mg) and one tablet of ritonavir (100 mg) taken together twice daily for five days.
- Administration: Take the tablets orally, with or without food. It is important to follow the prescribed dosing schedule closely.
Common side effects may include:
- Diarrhea
- Nausea
- Fatigue
- Headache
- Altered taste
- Drug Interactions: Ritonavir can interact with many medications. Inform healthcare providers about all medications being taken to avoid potentially harmful interactions.
- Hepatic Impairment: Use with caution in patients with liver disease, as dosage adjustments may be necessary.
- Hypersensitivity: Known allergies to nirmatrelvir, ritonavir, or any components of the formulation.
- Severe Liver Disease: Contraindicated in patients with severe hepatic impairment.
Ritonavir can affect the metabolism of various drugs, including:
- Anticoagulants
- Antiepileptics
- Certain antihypertensives
- Store Paxista at room temperature, away from moisture and light. Keep out of reach of children.
- Educate patients on the importance of starting treatment as soon as possible after a positive COVID-19 test and within five days of symptom onset.
- Advise them to report any severe or persistent side effects, especially signs of liver issues (e.g., jaundice, dark urine).
- Discuss potential drug interactions and the importance of informing healthcare providers of all medications and supplements being taken.
Paxista (Nirmatrelvir and Ritonavir) is a crucial treatment option for mild to moderate COVID-19 in high-risk patients. Adherence to dosing and awareness of potential interactions are key for maximizing therapeutic benefits while minimizing risks. Always consult a healthcare provider for personalized advice and guidance.
Bosentan Bosenat 125mg Tablet
Product Brochure
| Dose/Strength | 125 mg |
| Pharmacopoeia Standard | IP |
| Brand | Bosenat |
| Packaging Size | 10*10 tablets |
| Composition | Bosentan 125 mg |
| Manufactured By | Natco |
| Treatment | Aspiratory Blood Vessel Hypertension (PAH) |
| Brand Name | Bosenat 125 mg |
Active Ingredient: Bosentan
Uses:
Bosenat is primarily used for:
- Pulmonary Arterial Hypertension (PAH): To improve exercise ability and decrease the rate of clinical worsening in patients with PAH.
Bosentan is an endothelin receptor antagonist. It works by blocking the effects of endothelin-1, a substance in the blood that causes blood vessels to constrict. By inhibiting this action, Bosentan helps to relax and widen blood vessels, leading to decreased blood pressure in the pulmonary artery.
Dosage and Administration:- Typical Dosage: The usual starting dose is 62.5 mg taken orally twice daily, which may be increased to 125 mg twice daily based on the patient’s response and tolerance.
- Administration: Can be taken with or without food. It’s important to take it consistently at the same times each day.
- Hypersensitivity: Avoid in individuals with known allergies to Bosentan or any components of the formulation.
- Pregnancy: Not recommended during pregnancy due to potential harm to the fetus.
- Liver Function: Monitor liver function tests regularly, as Bosentan can cause liver enzyme elevations.
- Blood Pressure: Patients should be monitored for low blood pressure (hypotension).
- Drug Interactions: Inform healthcare providers of all medications being taken, as Bosentan can interact with other drugs.
- Headache
- Flushing
- Edema (swelling)
- Nasal congestion
- Liver enzyme elevation
- Liver dysfunction (e.g., jaundice, severe fatigue)
- Allergic reactions (e.g., rash, itching, swelling)
- Severe hypotension
Store Bosenat tablets at room temperature, away from moisture and light. Follow any specific storage guidelines provided with the product.
Patient Counseling Information:- Report Side Effects: Advise patients to notify their healthcare provider of any unusual symptoms or side effects, particularly signs of liver dysfunction.
- Adherence: Emphasize the importance of taking the medication as prescribed and not missing doses.
- Regular Monitoring: Stress the need for regular follow-up appointments for liver function tests and blood pressure monitoring.
Bosenat (Bosentan) 125 mg Tablets are an effective treatment for pulmonary arterial hypertension, helping to improve quality of life and exercise capacity. Proper adherence to the treatment regimen and monitoring for side effects are crucial for safety and effectiveness. Always consult a healthcare professional for personalized guidance regarding this medication.
50mg Trombonat Eltrombopag Olamine Tablet
Product Brochure
| Strength | 50 mg |
| Pack Size | 28 Tablets |
| Brand | Trombonat 50mg |
| Composition | Eltrombopag |
| Packaging Type | 4*7 Tablet |
| Manufactured By | Natco Pharma Ltd |
| Treatment | Severe Aplastic Anemia |
Overview: Trombonat contains Eltrombopag Olamine, a thrombopoietin receptor agonist used to treat low platelet counts in patients with certain blood disorders. It works by stimulating the thrombopoietin receptor on bone marrow cells, which promotes the production of platelets (cells responsible for blood clotting). This is particularly useful in conditions like chronic immune thrombocytopenia (ITP) and severe aplastic anemia.
Indications: Trombonat 50mg Tablet is indicated for:
- Chronic Immune Thrombocytopenia (ITP): Treatment of adults and children with ITP who have had an insufficient response to other treatments.
- Severe Aplastic Anemia: For patients with severe aplastic anemia who have not responded to immunosuppressive therapy.
- Chronic Hepatitis C: In combination with other drugs, to increase platelet count in patients undergoing interferon-based therapy.
Mechanism of Action: Eltrombopag binds to and activates the thrombopoietin receptor (TPOR) on hematopoietic stem cells in the bone marrow, leading to increased platelet production. By stimulating the production of platelets, it helps increase blood platelet counts in conditions where platelet production is insufficient.
Dosage and Administration:
- Chronic Immune Thrombocytopenia (ITP): The usual starting dose is 50mg once daily. For patients who do not achieve an adequate response, the dose may be increased to 75mg.
- Severe Aplastic Anemia: The typical dose is 50mg once daily, adjusted based on individual response and tolerability.
- Tablets should be taken once daily, with or without food. Do not crush or chew.
Side Effects: Common side effects include:
- Headache, nausea, and fatigue.
- Liver enzyme abnormalities (e.g., ALT, AST).
- Musculoskeletal pain or dizziness.
Serious side effects may include:
- Hepatotoxicity: Elevated liver enzymes, jaundice, or liver failure. Regular liver function tests are necessary.
- Bone marrow disorders: Eltrombopag may rarely cause bone marrow fibrosis or hematologic malignancies.
- Thromboembolic events: There may be an increased risk of blood clots in certain patients.
Precautions:
- Liver Function: Regular monitoring of liver function (ALT, AST, bilirubin) is required during treatment. Discontinue if significant liver toxicity occurs.
- Pregnancy and Breastfeeding: Use during pregnancy is not recommended due to potential fetal harm. Eltrombopag should be avoided while breastfeeding.
- Drug Interactions: Eltrombopag may interact with drugs that affect liver enzymes (e.g., CYP1A2, CYP2C8), affecting its metabolism. Inform your doctor of all medications being taken.
Storage: Store at room temperature (20°C to 25°C), away from moisture and light. Keep out of reach of children.
Conclusion: Trombonat (Eltrombopag Olamine) 50mg Tablet is an effective treatment for chronic immune thrombocytopenia (ITP) and severe aplastic anemia. By stimulating platelet production in the bone marrow, it helps improve platelet counts and reduce the risk of bleeding. Regular monitoring for liver function and other side effects is essential for safe use.
Tenolam E Tablets Lamivudine (300mg) + Tenofovir disoproxil fumarate (300mg) + Efavirenz (600mg)
Product Brochure
| Dose/Strength | 300mg/300mg/600mg |
| Pack Size | 30 tablets |
| Strength | Lamivudine 300 mg, Tenofovir Disoproxil Fumarate 300 mg, Efavirenz 600 mg |
| Brand | Tenolam E |
| Packaging Size | 1x30Tablets |
| Composition | Lamivudine 300 mg + Tenofovir Disoproxil Fumarate 300 mg + Efavirenz 600 mg |
| Brand Name | Tenolam E Tablets |
| Manufacturer By | Hetero Helthcare |
| Treatment | HIV Infection |
Tenolam E Tablets (Lamivudine 300 mg, Tenofovir Disoproxil Fumarate 300 mg, Efavirenz 600 mg)
Overview: Tenolam E is a fixed-dose combination antiretroviral medication used for the treatment of HIV-1 infection. It combines lamivudine, tenofovir disoproxil fumarate, and efavirenz to provide a comprehensive approach to managing the virus.
Indications:
- HIV Infection: Indicated for the treatment of HIV-1 infection in adults and pediatric patients as part of a comprehensive antiretroviral regimen.
Mechanism of Action:
- Lamivudine: A nucleoside reverse transcriptase inhibitor (NRTI) that blocks reverse transcriptase, preventing the conversion of viral RNA into DNA.
- Tenofovir Disoproxil Fumarate: Another NRTI that inhibits reverse transcriptase, reducing viral replication.
- Efavirenz: A non-nucleoside reverse transcriptase inhibitor (NNRTI) that binds to reverse transcriptase and inhibits its activity, further preventing viral replication.
Dosage and Administration:
- Recommended Dose: Typically, one tablet taken orally once daily.
- Administration: Can be taken with or without food, but taking it on an empty stomach is generally recommended to minimize side effects.
Side Effects: Common side effects may include:
- Nausea
- Dizziness
- Fatigue
- Headache
- Rash
- Possible changes in mood or sleep disturbances (particularly with efavirenz)
Warnings and Precautions:
- CNS Effects: Efavirenz can cause central nervous system (CNS) side effects; caution is advised in patients with a history of mental health issues.
- Liver Function: Regular monitoring of liver function is advised, particularly in patients with a history of liver disease.
- Renal Function: Monitor kidney function, especially in patients receiving tenofovir.
Contraindications:
- Hypersensitivity to any of the components.
- Severe liver impairment.
Drug Interactions: Tenolam E may interact with other medications, particularly those that affect liver enzymes. It is important for patients to inform their healthcare provider about all medications and supplements being taken.
Storage Instructions: Store at room temperature, away from moisture and light. Keep out of reach of children.
Patient Counseling Information:
- Advise patients to take the medication as prescribed and not to miss doses.
- Discuss the importance of regular follow-up appointments for monitoring viral load and overall health.
- Instruct patients to report any unusual side effects, especially related to mood changes or severe skin reactions.
Tenolam E Tablets (Lamivudine, Tenofovir Disoproxil Fumarate, and Efavirenz) are an effective treatment option for managing HIV-1 infection. Proper adherence to dosing, monitoring for side effects, and patient education are essential for optimizing treatment outcomes. Always consult a healthcare provider for personalized treatment recommendations.
Heptivite Tablet Multivitamine Tablets
Product Brochure
| Form | Tablet |
| Ideal For | Adults (Unisex) |
| Packaging Size | 5*10 Tablets |
| Composition | Multivitamine Tablets |
| Brand | Heptivite |
| Manufactured By | HETERO HEALTHCARE LTD |
| Usage/Application | Heavy drinker and non-alcoholic steatohepatitis Gentle hepatic encephalopathy Liver cirrhosis |
| Packaging Type | Box |
| Pack Type | Strip |
Overview
Heptivite is a multivitamin supplement designed to provide essential vitamins and minerals that may be lacking in the diet. It supports overall health and well-being.
- Nutritional Support: Used to supplement dietary intake of vitamins and minerals.
- Deficiency Prevention: Helps prevent deficiencies in individuals with inadequate dietary intake, certain medical conditions, or increased nutritional needs.
Heptivite typically contains a range of essential vitamins and minerals, including:
- Vitamins: A, C, D, E, K, and various B vitamins (B1, B2, B3, B6, B12, folic acid)
- Minerals: Iron, calcium, magnesium, zinc, selenium, and others
- Nutrient Supplementation: Each vitamin and mineral plays a specific role in bodily functions, including metabolism, immune function, and cellular repair.
- Dosage: The typical adult dosage is one tablet daily, or as directed by a healthcare provider.
- Administration: Take with water, preferably with food to enhance absorption and minimize gastrointestinal discomfort.
Heptivite is generally well-tolerated, but some individuals may experience:
- Nausea
- Stomach upset
- Constipation
- Allergic reactions (rare)
- Excessive Intake: Avoid exceeding the recommended dosage, as high levels of certain vitamins and minerals can lead to toxicity.
- Medical Conditions: Consult a healthcare provider before use if you have any medical conditions, are pregnant, or are taking other medications.
- Hypersensitivity: Known allergies to any ingredients in the formulation.
Heptivite may interact with certain medications, particularly those that affect nutrient absorption (e.g., some antacids, antibiotics). Always inform healthcare providers about all medications and supplements being taken.
Storage Instructions- Store Heptivite tablets at room temperature, away from moisture and light. Keep out of reach of children.
- Educate patients on the importance of a balanced diet alongside supplementation.
- Advise them to report any adverse reactions or symptoms of overdose, such as nausea, vomiting, or unusual fatigue.
Heptivite Tablets are a comprehensive multivitamin supplement that supports nutritional health. Proper usage and adherence to recommended dosages are essential for achieving optimal benefits. Always consult a healthcare provider for personalized advice and guidance.
Itraconazole & Terbinafine Tablets ( Terbiface Plus Tablets)
Product Brochure
| Dosage Form | Tablet |
| Strength | 500 mg |
| Brand | Terbiface Plus |
| Composition | Itraconazole & Terbinafine |
| Packaging Size | 10*1*4 Capsule |
| Brand Name | Terbiface Plus |
| Manufactured By | Healing Pharma India Pvt Ltd |
| Usage/Application | Parasitic Skin Diseases |
Overview
Terbiface Plus combines itraconazole and terbinafine, two antifungal agents, used to treat various fungal infections. This combination targets a broad spectrum of fungi, making it effective for various dermatological and systemic conditions.
- Fungal Infections: Effective in treating:
- Dermatophyte infections (e.g., ringworm, athlete's foot)
- Onychomycosis (fungal nail infections)
- Systemic fungal infections (e.g., histoplasmosis, blastomycosis)
- Itraconazole: An azole antifungal that works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to cell death.
- Terbinafine: A squalene epoxidase inhibitor that also disrupts ergosterol synthesis but does so through a different pathway, making it effective against certain fungi, especially dermatophytes.
- Dosage: The specific dosage should be determined by a healthcare provider based on the type and severity of the infection. A common regimen may involve taking one tablet daily or as directed.
- Administration: Tablets should be taken orally, preferably with food to enhance absorption.
Common side effects may include:
- Nausea
- Abdominal pain
- Diarrhea
- Headache
- Rash
- Liver Function: Monitor liver function tests, as both itraconazole and terbinafine can affect liver enzymes.
- Drug Interactions: Caution is advised when used with other medications, especially those that affect liver metabolism.
- Heart Failure: Itraconazole can exacerbate heart failure; use with caution in patients with a history of cardiac issues.
- Hypersensitivity: Known allergies to itraconazole, terbinafine, or any components of the formulation.
- Severe Liver Disease: Contraindicated in patients with severe hepatic impairment.
Terbiface Plus may interact with:
- CYP450 Inhibitors/Inducers: Both antifungals can affect the metabolism of other drugs metabolized by the liver, requiring careful monitoring and possible dose adjustments.
- Other Antifungals: Increased risk of side effects when combined with other antifungal medications.
- Store Terbiface Plus at room temperature, away from moisture and light. Keep out of reach of children.
- Educate patients about the importance of completing the full course of treatment, even if symptoms improve.
- Advise them to report any signs of liver dysfunction (e.g., jaundice, dark urine) or severe allergic reactions.
- Discuss potential side effects and the importance of regular follow-ups.
Terbiface Plus (Itraconazole and Terbinafine Tablets) is an effective antifungal treatment for a range of fungal infections. Proper usage, monitoring for side effects, and patient education are essential for achieving optimal outcomes. Always consult a healthcare provider for personalized advice and guidance.
Tavin L Tablets
Product Brochure
| Dose/Strength | 300 mg |
| Packaging Size | 1x30Tablets |
| Packaging Type | Box |
| Manufacturer | Emcure Pharmaceuticals Ltd |
| Shelf Life | 24 Month |
| Usage / Application | Hospital |
Tavin L Tablets
Indications:Tavin L is indicated for:
- The treatment of HIV-1 infection in combination with other antiretroviral agents.
- It may also be used in patients with a history of prior antiretroviral therapy failure.
Tavin L is a combination medication that typically includes tenofovir disoproxil fumarate (TDF) and lamivudine (3TC).
- Tenofovir is a nucleotide reverse transcriptase inhibitor (NRTI) that works by inhibiting the reverse transcriptase enzyme, preventing viral replication.
- Lamivudine is also an NRTI that interferes with the viral RNA synthesis, further inhibiting viral replication.
- Dosage: The usual recommended dose is one tablet taken orally once daily. The specific dosage may vary based on the patient's medical history and response to treatment.
- Administration: Tavin L can be taken with or without food. It is important to adhere to the prescribed regimen for optimal effectiveness.
- Hypersensitivity to tenofovir, lamivudine, or any components of the formulation.
- Significant renal impairment (specific dosage adjustments may be necessary).
- Liver Disease: Caution is advised in patients with pre-existing liver disease or hepatitis B infection, as discontinuation may lead to hepatitis flare.
- Renal Impairment: Monitor kidney function regularly, as TDF can affect renal function.
- Bone Health: Long-term use of tenofovir may be associated with decreased bone mineral density.
Common side effects:
- Nausea
- Diarrhea
- Fatigue
- Headache
- Dizziness
Serious side effects:
- Lactic acidosis
- Hepatotoxicity
- Severe allergic reactions
- Renal toxicity
Tavin L may interact with other medications, particularly those affecting renal function or that are metabolized by the liver. Inform healthcare providers of all medications being taken.
Storage:Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from moisture and light. Keep out of reach of children.
Patient Counseling Information:- Advise patients to take the medication exactly as prescribed and not to miss doses.
- Discuss potential side effects and the importance of regular follow-up appointments for monitoring.
- Encourage patients to report any signs of liver problems, such as jaundice, dark urine, or persistent abdominal pain.
Tavin L Tablets are an effective treatment option for HIV-1 infection, providing a combination of active agents that help control viral replication. Continuous communication with healthcare providers is essential for managing potential side effects and ensuring optimal treatment outcomes. Always consult a healthcare professional for personalized medical advice.
Twinaqt 50mg + 300mg Tablets
Product Brochure
| Strength | Dolutegravir (50 mg ) & Tenofovir Disoproxil Fumarate ( 300 mg ) |
| Packaging Size | 1x30 |
| Composition | Dolutegravir 50 mg, Lamivudine 300 mg |
| Brand Name | Twinaqt 50 mg/300 mg |
| Manufacturer By | Emcure Pharmaceuticals Ltd |
| Treatment | HIV Infection |
Twinaqt (Dolutegravir + Tenofovir Disoproxil Fumarate) 50 mg + 300 mg TabletsOverview: Twinaqt is a fixed-dose combination antiretroviral medication containing dolutegravir and tenofovir disoproxil fumarate, used for the treatment of HIV-1 infection. This combination therapy helps suppress viral replication and improves immune function.Indications:HIV Infection: Indicated for the treatment of HIV-1 infection in adults and pediatric patients as part of a comprehensive antiretroviral regimen.Mechanism of Action:Dolutegravir: An integrase strand transfer inhibitor (INSTI) that inhibits the integrase enzyme, preventing the integration of viral DNA into the host genome, thereby halting viral replication.Tenofovir Disoproxil Fumarate: A nucleoside reverse transcriptase inhibitor (NRTI) that inhibits reverse transcriptase, preventing the conversion of viral RNA into DNA.Dosage and Administration:Recommended Dose: Typically, one tablet taken orally once daily.Administration: Can be taken with or without food. Consistency in timing is important for optimal effectiveness.Side Effects: Common side effects may include:InsomniaHeadacheFatigueNauseaDiarrheaPotential changes in kidney functionWarnings and Precautions:Renal Function: Regular monitoring of kidney function is recommended, especially in patients with pre-existing kidney issues.Liver Function: Monitor liver function, particularly in patients with a history of liver disease.Hypersensitivity Reactions: Be alert for signs of serious allergic reactions.Contraindications:Hypersensitivity to dolutegravir, tenofovir, or any components of the formulation.Not recommended during pregnancy unless the benefits outweigh the risks.Drug Interactions: Twinaqt may interact with various medications, particularly those affecting liver enzymes. Patients should inform their healthcare provider about all medications and supplements being taken.Storage Instructions: Store at room temperature, away from moisture and light. Keep out of reach of children.Patient Counseling Information:Advise patients to take the medication as prescribed and not to miss doses.Discuss the importance of regular follow-up appointments for monitoring HIV viral load and overall health.Instruct patients to report any unusual side effects, particularly those related to kidney function or severe allergic reactions.ConclusionTwinaqt (Dolutegravir + Tenofovir Disoproxil Fumarate) 50 mg + 300 mg Tablets are an effective treatment option for managing HIV-1 infection. Proper adherence to dosing, monitoring for side effects, and patient education are essential for optimizing treatment outcomes. Always consult a healthcare provider for personalized treatment recommendations.
Nirmatrelvir 150 Mg Tablet & Ritonovir IP 100 Mg Tablet Combipack (Paxobrook)
Product Brochure
| Strength | 150 mg + 100 mg |
| Pack Size | 10 tablets |
| Brand | Paxobrook |
| Manufacturer | Healing Pharma Pvt Ltd |
| Packaging Size | 10 Tablet in 1 Strip |
| Composition | Nirmatrelvir + Ritonavir |
| Treatment | Coronavirus Disease (covid-19) |
Overview: Paxobrook is a combination medication containing nirmatrelvir and ritonavir, indicated for the treatment of COVID-19 in patients at high risk of progression to severe disease. Nirmatrelvir is an antiviral that inhibits the SARS-CoV-2 protease, while ritonavir enhances the effectiveness of nirmatrelvir by inhibiting its metabolism.
Indications:
- COVID-19 Treatment: Used for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years and older) who are at high risk for progressing to severe disease, including hospitalization or death.
Components:
- Nirmatrelvir: 150 mg per tablet.
- Ritonavir: 100 mg per tablet.
Dosage and Administration:
- Typical Dosage: The standard regimen is 300 mg of nirmatrelvir (two tablets) and 100 mg of ritonavir (one tablet) taken orally twice daily for five days.
- Administration: Tablets should be taken together with food to improve absorption and minimize gastrointestinal side effects.
Side Effects:
- Common: Nausea, diarrhea, headache, and fatigue.
- Serious: Potential for liver enzyme elevations, drug interactions due to ritonavir, and hypersensitivity reactions.
Contraindications:
- Hypersensitivity: Known allergy to nirmatrelvir, ritonavir, or any of the formulation's components.
- Severe Liver Impairment: Use is contraindicated in patients with severe hepatic dysfunction.
Warnings and Precautions:
- Drug Interactions: Ritonavir can interact with many medications; patients should inform healthcare providers of all medications they are taking.
- Liver Function Monitoring: Liver function tests should be monitored periodically during treatment.
- Pregnancy and Lactation: Should be used with caution in pregnant or breastfeeding individuals, with a risk-benefit assessment.
Storage: Store Paxobrook at room temperature, away from moisture and heat. Keep out of reach of children.
Patient Counseling:
- Explain the purpose of Paxobrook in treating COVID-19 and the importance of starting treatment early after diagnosis.
- Discuss potential side effects and the necessity of reporting any severe reactions or unusual symptoms.
- Emphasize adherence to the prescribed regimen and the importance of follow-up care.
Conclusion: Paxobrook (Nirmatrelvir 150 mg and Ritonavir 100 mg) Combipack is an effective treatment option for patients with mild to moderate COVID-19 at high risk for severe disease. Proper usage, monitoring, and patient education are essential for optimizing therapeutic outcomes and minimizing risks. Always consult a healthcare provider for personalized medical advice.
Alpha Ketoanalogue Tablets ( Nefroheal Tablet)
Product Brochure
| Brand | Nefroheal |
| Treatment | Chronic Kidney Disease |
| Packaging Size | 10*10 Tablets |
| Packaging Type | Box |
| Manufacturer | Healing Pharma India Pvt Ltd |
| Composition | Alpha Ketoanalogue |
| Brand Name | Nefroheal Tablet |
| Usage/Application | Therapy of Chronic kidney disease |
Overview
Nefroheal contains alpha-ketoanalogue compounds, which are designed to provide a source of essential amino acids while reducing the intake of nitrogenous waste products. This formulation is particularly beneficial for patients with chronic kidney disease (CKD).
- Chronic Kidney Disease: Used as a dietary supplement in patients with CKD to help manage protein intake and minimize uremic symptoms.
- Protein Restriction: Aids in providing essential nutrients while allowing for dietary protein restriction.
- Nitrogenous Waste Reduction: Alpha-ketoanalogues serve as substitutes for essential amino acids, allowing for adequate nutrition while limiting the generation of urea and other nitrogenous waste products that can accumulate in CKD.
- Dosage: The recommended dosage varies based on the severity of kidney disease and dietary protein restriction, typically ranging from 1 to 3 tablets daily. Specific dosing should be determined by a healthcare provider.
- Administration: Take the tablets orally, preferably with meals to enhance absorption.
Common side effects may include:
- Gastrointestinal discomfort (nausea, bloating)
- Diarrhea
- Altered taste perception
- Nutritional Monitoring: Regular monitoring of nutritional status is advised to ensure adequate protein and amino acid intake.
- Individualized Treatment: Dosage should be tailored to the individual’s dietary needs and kidney function.
- Hypersensitivity: Known allergies to alpha-ketoanalogue compounds or any components of the formulation.
- Severe Liver Disease: Caution is advised, as metabolic processing may be affected.
Nefroheal is generally well-tolerated, but it’s important to inform healthcare providers of all medications being taken, especially those that affect kidney function.
Storage Instructions- Store Nefroheal at room temperature, away from moisture and light. Keep out of reach of children.
- Educate patients on the importance of adhering to the prescribed regimen and dietary recommendations.
- Advise them to report any gastrointestinal issues or changes in health status.
- Encourage regular follow-up appointments to monitor kidney function and nutritional status.
Nefroheal (Alpha Ketoanalogue Tablets) is a valuable dietary supplement for managing chronic kidney disease and providing essential amino acids while minimizing nitrogenous waste. Proper usage, monitoring, and patient education are crucial for achieving optimal outcomes. Always consult a healthcare provider for personalized advice and guidance.
40mg Enzalutamide Tablet
Product Brochure
| Strength | 40 mg |
| Dosage Form | Capsule |
| Brand | Enzana |
| Pack Type | 4*7 Capsules |
| Compostion | Enzalutamide |
| Manufacturer | Hetero Healthcare |
| Treatment | Prostate Cancer |
Apigat 5 mg Apixaban Tablet
Product Brochure
| Strength | 5 mg |
| Brand | Apigat 5 |
| Pack Size | 30 tablets |
| Pack Type | 30 Tablets in 1 Bottle |
| Salt Composition | Apixaban 5 mg |
| Brand Name | Apigat 5 Table |
| Manufactured By | Natco Pharma Ltd. |
| Treatment | Blood Clusters |
Overview:
Apigat 5 Tablet contains Apixaban, an oral anticoagulant used to reduce the risk of blood clots in conditions such as atrial fibrillation, deep vein thrombosis (DVT), and pulmonary embolism (PE). Apixaban works by inhibiting factor Xa, a key enzyme in the coagulation cascade, which prevents the conversion of prothrombin to thrombin, thereby reducing clot formation.
Indications:
Apigat 5 Tablet is indicated for:
- Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
- Treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE).
- Prevention of DVT and PE recurrence in patients who have completed initial therapy.
Mechanism of Action:
Apixaban selectively inhibits factor Xa, an enzyme that plays a critical role in the blood coagulation process. By inhibiting factor Xa, Apixaban reduces thrombin generation and prevents the formation of fibrin clots, thereby reducing the risk of thromboembolic events such as stroke, DVT, and PE.
Dosage and Administration:
- Atrial fibrillation: 5 mg twice daily, unless the patient meets certain criteria (age ≥80 years, weight ≤60 kg, or serum creatinine ≥1.5 mg/dL), in which case the dose may be reduced to 2.5 mg twice daily.
- DVT/PE treatment: Initially, 10 mg twice daily for the first 7 days, followed by 5 mg twice daily for long-term treatment.
- DVT/PE prevention (after initial treatment): 2.5 mg twice daily.
Tablets should be taken with or without food.
Side Effects:
Common side effects include:
- Bleeding: Bruising, nosebleeds, or bleeding gums.
- Gastrointestinal issues: Nausea, diarrhea, or indigestion.
- Fatigue and headache.
Serious side effects may include:
- Severe bleeding (e.g., gastrointestinal bleeding, intracranial hemorrhage).
- Hepatotoxicity: Elevated liver enzymes.
- Hypersensitivity reactions: Rash, swelling, or difficulty breathing.
Precautions:
- Bleeding risk: Apixaban increases the risk of bleeding, especially in patients with active bleeding or a history of bleeding disorders.
- Renal or hepatic impairment: Dose adjustment may be necessary for patients with significant kidney or liver disease.
- Pregnancy: Not recommended during pregnancy unless absolutely necessary, as safety has not been established.
- Concomitant medications: Careful monitoring is required if used with other anticoagulants or drugs that affect bleeding risk.
Storage:
Store at room temperature (20°C–25°C) in a tightly closed container, away from moisture and light.
Conclusion:
Apigat 5 (Apixaban) Tablet is a potent anticoagulant used to prevent and treat thromboembolic events such as stroke, DVT, and PE. It offers a convenient, oral alternative to traditional anticoagulants and requires careful monitoring for bleeding risks, especially in patients with renal or hepatic impairment.
Apigat 2.5 mg Apixaban Tablet
Product Brochure
| Strength | 2.5 mg |
| Brand | Apigat 2.5 |
| Pack Size | 30 tablets |
| Pack Type | 30 Tablets in 1 Bottle |
| Salt Composition | Apixaban 2.5 mg |
| Brand Name | Apigat 2.5 mg Tablet |
| Manufactured By | Natco Pharma Ltd |
| Treatment | Blood Clusters |
Overview: Apigat 2.5 contains Apixaban, an oral anticoagulant (blood thinner) that works by inhibiting Factor Xa, an enzyme crucial for blood clotting. Apixaban is used to prevent and treat various thromboembolic conditions, including deep vein thrombosis (DVT), pulmonary embolism (PE), and to reduce the risk of stroke in patients with atrial fibrillation (AF) and other clotting disorders.
Indications: Apigat 2.5mg Tablet is indicated for:
- Prevention of stroke and systemic embolism in adults with non-valvular atrial fibrillation (AF).
- Treatment and prevention of recurrence of deep vein thrombosis (DVT) and pulmonary embolism (PE).
- Prophylaxis of DVT following hip or knee replacement surgery.
Mechanism of Action: Apixaban works by selectively inhibiting Factor Xa, an enzyme that plays a central role in the coagulation cascade. By inhibiting Factor Xa, Apixaban prevents the conversion of prothrombin to thrombin, thereby reducing the formation of fibrin and the clotting process.
Dosage and Administration:
- Atrial Fibrillation: The recommended dose is 5mg twice daily, but for patients with certain risk factors (e.g., elderly, renal impairment), the dose may be reduced to 2.5mg twice daily.
- DVT/PE treatment: Initial dose of 10mg twice daily for the first 7 days, followed by 5mg twice daily for maintenance.
- DVT/PE Prophylaxis: 2.5mg twice daily after surgery.
The tablets should be taken with or without food.
Side Effects: Common side effects include:
- Bleeding events: Easy bruising, nosebleeds, or bleeding gums.
- Gastrointestinal disturbances: Nausea, abdominal pain.
- Fatigue, headache, or dizziness.
Serious side effects may include:
- Severe bleeding (e.g., internal bleeding, hematuria, or gastrointestinal bleeding).
- Anemia, thrombocytopenia (low platelet count).
Precautions:
- Bleeding Risk: Apixaban increases the risk of bleeding, including intracranial hemorrhage or spinal hematoma. Use with caution in patients with a history of bleeding disorders.
- Renal and Hepatic Impairment: Adjust dosage in patients with renal or liver dysfunction.
- Pregnancy and Breastfeeding: Apixaban should not be used during pregnancy unless clearly necessary. It is not recommended during breastfeeding.
- Drug Interactions: Apixaban can interact with other anticoagulants, antiplatelet agents, or drugs that affect liver enzymes (CYP3A4 inhibitors or inducers).
Storage: Store at room temperature (20°C to 25°C), away from moisture and light. Keep out of reach of children.
Conclusion: Apigat 2.5 (Apixaban) Tablet is an effective oral anticoagulant for preventing and treating thromboembolic conditions, such as stroke prevention in atrial fibrillation, DVT, and PE. Due to its bleeding risk, it is important for patients to be monitored regularly, particularly for signs of bleeding. Proper usage under medical supervision is key to its safe and effective use.
Piracetam And Citicoline (Strocit Plus Tablet)
Product Brochure
| Strength | 500mg/800mg |
| Combination | With Piracetam |
| Usage | Head Injury |
| Pack Size | 5*10 Tablet |
| Composition | Citicoline 500mg + Piracetam 800mg |
| Brand Name | Strocit Plus Tablet |
| Manufactured By | Sun Pharmaceutical Industries Ltd |
| Usage/Application | Rehabilitation of Stroke |
Overview
Strocit Plus is a combination medication that contains piracetam and citicoline. It is used to enhance cognitive function and support brain health.
- Cognitive Impairment: Used in the management of cognitive dysfunction, including conditions like dementia, stroke recovery, and other neurological disorders.
- Memory Enhancement: Aimed at improving memory, attention, and learning abilities.
- Piracetam: A nootropic agent that enhances cognitive function by improving neuronal metabolism and increasing blood flow to the brain. It modulates neurotransmitter activity, particularly acetylcholine.
- Citicoline: A precursor to phosphatidylcholine, it supports the synthesis of phospholipids in cell membranes and helps in the repair and maintenance of neurons. It also enhances dopamine receptor sensitivity and promotes overall brain health.
- Dosage: The typical dosage is one tablet taken 1-2 times daily, or as directed by a healthcare provider. The dosage may vary based on individual needs and response.
- Administration: Tablets should be taken orally, with or without food. It’s important to follow the prescribed regimen.
Common side effects may include:
- Nausea
- Headache
- Insomnia
- Gastrointestinal disturbances
- Seizure Disorders: Use with caution in patients with a history of seizures; monitor closely for any adverse effects.
- Pregnancy and Lactation: Safety during pregnancy and breastfeeding has not been established; consult a healthcare provider before use.
- Hypersensitivity: Known allergies to piracetam, citicoline, or any components of the formulation.
- Severe Renal Impairment: Caution is advised in patients with significant renal dysfunction.
Strocit Plus may interact with:
- Anticoagulants: Caution in patients taking blood thinners, as citicoline may enhance their effects.
- Other Nootropics: Monitor for additive effects when used with other cognitive enhancers.
- Store Strocit Plus at room temperature, away from moisture and light. Keep out of reach of children.
- Educate patients on the importance of adherence to the prescribed regimen for optimal cognitive benefits.
- Advise them to report any unusual symptoms, especially gastrointestinal issues or changes in mental status.
Strocit Plus (Piracetam and Citicoline Tablet) is a valuable option for supporting cognitive function and brain health. Proper usage, monitoring for side effects, and patient education are essential for achieving optimal outcomes. Always consult a healthcare provider for personalized advice and guidance.
Zyloric 300 mg Tablet
Product Brochure
| Strength | 300 mg |
| Packaging Size | 10* 10 Tablets |
| Composition | Allopurinol 300mg |
| Brand Name | Zyloric 300 mg |
| Manufacturer | Glaxo SmithKline Pharmaceuticals Ltd |
| Treatment | Treat Gout |
Overview
Zyloric contains allopurinol, a medication used to lower uric acid levels in the blood, primarily for the management of gout and certain types of kidney stones.
- Chronic Gout: Used for the long-term management of hyperuricemia associated with gout to prevent gout attacks.
- Hyperuricemia: Management of hyperuricemia in patients receiving chemotherapy or radiation therapy for certain cancers, which can lead to increased uric acid levels.
Allopurinol works by:
- Inhibiting Xanthine Oxidase: It reduces the production of uric acid by inhibiting the enzyme xanthine oxidase, which converts hypoxanthine and xanthine into uric acid.
- Dosage: The usual starting dose is 100 to 300 mg per day, depending on the severity of hyperuricemia and clinical response. Dosage can be adjusted based on uric acid levels.
- Administration: Tablets should be taken orally, preferably after meals, to minimize gastrointestinal irritation. Adequate hydration is important to reduce the risk of kidney stones.
Common side effects may include:
- Rash
- Nausea
- Diarrhea
- Liver enzyme elevation
- Rarely, hypersensitivity reactions (such as Stevens-Johnson syndrome)
- Skin Reactions: Monitor for skin rash, especially during the first few weeks of treatment; discontinue use if severe rash occurs.
- Hepatic Function: Regular monitoring of liver function tests is recommended.
- Kidney Function: Assess renal function before starting treatment and adjust dosage as necessary.
- Hypersensitivity: Known allergies to allopurinol or any components of the formulation.
- Acute Gout Attacks: Not recommended during acute gout flares; treatment should begin after the attack has resolved.
Allopurinol may interact with:
- Azathioprine and Mercaptopurine: Increased toxicity; dosage adjustment may be necessary.
- Warfarin: May enhance the anticoagulant effect; monitor INR closely.
- Store Zyloric at room temperature, away from moisture and light. Keep out of reach of children.
- Educate patients on the importance of adherence to the prescribed regimen and the need for regular follow-ups to monitor uric acid levels.
- Advise them to maintain adequate fluid intake and report any skin rashes, gastrointestinal issues, or signs of liver dysfunction.
Zyloric (Allopurinol 300 mg Tablets) is an effective option for managing hyperuricemia in patients with gout and certain cancer treatments. Proper administration, monitoring for side effects, and patient education are crucial for achieving optimal treatment outcomes. Always consult a healthcare provider for personalized advice and guidance.
Fincar Finasteride 5mg Tablets
Product Brochure
| Strength | 5 mg |
| Packaging Size | 1*10 Tablets |
| Dose | 5 mg |
| Manufacturer | Cipla Ltd |
| Treatment | Hair loss |
| Pack Size | 10 Tablet in 1 Strip |
| Composition (Salt) | Finasteride 5 mg |
| Brand Name | Fincar 5 mg |
Active Ingredient: Finasteride
Uses:
Fincar is primarily used to treat:
- Benign Prostatic Hyperplasia (BPH): Enlarged prostate in men, helping to reduce symptoms such as difficulty urinating.
- Male Pattern Baldness: Used to promote hair regrowth in men with androgenetic alopecia.
Finasteride works by inhibiting the enzyme 5-alpha-reductase, which converts testosterone into dihydrotestosterone (DHT). DHT is linked to both prostate enlargement and hair loss. By reducing DHT levels, Finasteride helps shrink the prostate and may improve hair growth.
Dosage and Administration:- Typical Dosage: The usual dose for BPH is 5 mg taken once daily. For male pattern baldness, the same dosage is generally used.
- Administration: Can be taken with or without food. It’s important to take it consistently at the same time each day.
- Hypersensitivity: Avoid in patients with known allergies to Finasteride or its components.
- Pregnancy: Not to be used by women who are pregnant or may become pregnant, as it can cause harm to a developing fetus.
- Prostate Cancer: Finasteride may increase the risk of high-grade prostate cancer; regular screenings are advised.
- Liver Function: Caution in patients with liver disease; liver function tests may be necessary.
- Blood Donation: Men taking Finasteride should not donate blood until at least 1 month after stopping the medication, as it may harm a developing fetus if transfused.
- Decreased libido
- Erectile dysfunction
- Ejaculation disorders
- Breast tenderness or enlargement
- Allergic reactions (e.g., rash, itching, swelling)
- Breast lumps or discharge
- Depression or mood changes
Store Fincar tablets at room temperature, away from moisture and light. Follow any specific storage guidelines provided with the product.
Patient Counseling Information:- Report Side Effects: Advise patients to notify their healthcare provider of any unusual symptoms or side effects.
- Adherence: Emphasize the importance of taking the medication as prescribed and attending regular follow-up appointments.
Fincar (Finasteride) 5 mg Tablets are effective for managing symptoms of BPH and treating male pattern baldness. Proper use and adherence to the treatment plan are essential for achieving desired outcomes. Always consult a healthcare professional for personalized guidance regarding this medication.
Procarbazine Tablets(Hodpro 50mg Tablets)
Product Brochure
| Strength | 50 mg |
| Pack Size | 50 capsules |
| Brand | Hodpro 50mg Tablets |
| Packaging Size | 10 Capsules in 1 strip |
| Composition | Procarbazine 50 mg |
| Manufacturer | Neon Laboratories Ltd |
| Treatment | Hodgkin's disease |
Overview: Procarbazine, marketed as Hodpro 50 mg tablets, is an alkylating agent used primarily in chemotherapy. It is commonly prescribed for the treatment of certain types of cancers, notably Hodgkin lymphoma and brain tumors.
Indications:
- Hodgkin Lymphoma: Often used as part of combination chemotherapy regimens.
- Other Cancers: May also be used for other malignancies as determined by a healthcare provider.
Mechanism of Action: Procarbazine works by interfering with the DNA of cancer cells, preventing them from dividing and growing. It is a pro-drug that gets converted into active metabolites that alkylate DNA.
Dosage and Administration:
- Dosage: The dosage of Hodpro can vary based on the specific treatment plan. A common starting dose might be 50 mg to 250 mg per day, depending on the regimen.
- Administration: Taken orally, with or without food. It is crucial to follow the prescribed schedule closely.
Contraindications:
- Hypersensitivity: Known allergies to procarbazine or any of its components.
- Pregnancy and Breastfeeding: Not recommended due to potential harm to the fetus or nursing infant.
Warnings and Precautions:
- Bone Marrow Suppression: Procarbazine can lead to decreased blood cell counts; regular monitoring is essential.
- Interactions: It can interact with other medications, including monoamine oxidase inhibitors (MAOIs), and should be used with caution in patients taking these drugs.
- Alcohol: Avoid alcohol, as it may increase side effects.
Common Side Effects:
- Nausea and vomiting
- Fatigue
- Loss of appetite
- Low blood cell counts (anemia, leukopenia, thrombocytopenia)
Serious Side Effects:
- Severe allergic reactions
- Signs of infection (fever, chills)
- Liver toxicity
Storage Instructions: Store at room temperature, away from moisture and light. Follow specific storage instructions provided on the product label.
Patient Counseling Information:
- Side Effects: Advise patients to report any severe or unusual side effects to their healthcare provider.
- Regular Monitoring: Emphasize the importance of regular blood tests to monitor for side effects.
Conclusion: Hodpro (Procarbazine 50 mg) is a critical medication for treating certain cancers. Patients should adhere to their treatment plan and maintain open communication with healthcare providers to ensure safety and efficacy. Always consult a healthcare professional for personalized medical advice.
Abacavir & Lamivudine Tablets ( Abec- L Tablets)
Product Brochure
| Packaging Size | 30 Tablets |
| Brand | Abec-L Tablets |
| Manufactured by | Emcure Pharmaceuticals Ltd |
| Treatment | HIV infection |
| Strength | 600mg/300mg |
| Composition | Abacavir ( 600 mg ), Lamivudine ( 300 mg ) |
| Dose/Strength | Abacavir 600 mg, Lamivudine 300 mg |
Abec-L (Abacavir & Lamivudine) Tablets
Overview: Abec-L is a fixed-dose combination tablet that contains two antiretroviral medications: abacavir and lamivudine. This combination is used in the treatment of HIV-1 infection, helping to reduce viral load and improve immune function.
Indications:
- HIV Infection: Indicated for the treatment of HIV-1 infection in adults and pediatric patients, typically as part of a combination antiretroviral therapy.
Mechanism of Action:
- Abacavir: A nucleoside reverse transcriptase inhibitor (NRTI) that inhibits the reverse transcriptase enzyme, blocking the conversion of viral RNA into DNA and preventing replication of the virus.
- Lamivudine: Another NRTI that works similarly to abacavir, also inhibiting reverse transcriptase to limit HIV replication.
Dosage and Administration:
- Recommended Dose: The typical dose for adults is one tablet taken orally once daily. In pediatric patients, the dose is based on body weight.
- Administration: Can be taken with or without food. It is important to take it at the same time each day for optimal effectiveness.
Side Effects: Common side effects may include:
- Nausea
- Fatigue
- Headache
- Rash
- Risk of hypersensitivity reactions (especially with abacavir)
- Potential for lactic acidosis (rare but serious)
Warnings and Precautions:
- Hypersensitivity Reaction: Abacavir can cause serious allergic reactions; patients should be screened for the HLA-B*5701 allele before starting treatment.
- Liver Function: Monitor liver function tests regularly, particularly in patients with a history of liver disease.
- Lactic Acidosis: Caution is advised due to the risk of lactic acidosis, especially in women and patients with obesity.
Contraindications:
- Hypersensitivity to abacavir or lamivudine or any components of the formulation.
- Severe hepatic impairment.
Drug Interactions: Abec-L may interact with other medications, particularly those affecting liver metabolism. Patients should inform their healthcare provider about all medications, including over-the-counter drugs and supplements.
Storage Instructions: Store at room temperature, away from moisture and light. Keep out of reach of children.
Patient Counseling Information:
- Advise patients to take the medication as prescribed and not to miss doses for optimal effectiveness.
- Discuss the importance of regular follow-up appointments for monitoring health and viral load.
- Instruct patients to report any unusual side effects, especially symptoms of hypersensitivity or liver dysfunction.
Abec-L (Abacavir & Lamivudine Tablets) is an effective treatment option for managing HIV-1 infection. Adherence to dosing, monitoring for side effects, and patient education are crucial for achieving optimal treatment outcomes. Always consult a healthcare provider for personalized treatment recommendations.
Finerenone Kerendia 10 Mg Tablet
Product Brochure
| Strength | 10 mg |
| Brand | Kerendia |
| Treatment | Chronic Kidney Disease |
| Packaging Size | 14 tablets in 1 strip |
| Packaging Type | Strips |
| Composition | Finerenone film coated tablets 10 mg |
| Brand Name | Kerendia |
| Manufacturer | Bayer Zydus Pharma Pvt Ltd |
Overview
Kerendia contains finerenone, a non-steroidal mineralocorticoid receptor antagonist (MRA) used primarily to manage chronic kidney disease (CKD) in patients with type 2 diabetes.
- Chronic Kidney Disease: Used to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular events in adults with CKD associated with type 2 diabetes.
- Mineralocorticoid Receptor Antagonism: Finerenone selectively blocks mineralocorticoid receptors, which helps reduce inflammation and fibrosis in the kidneys, thereby slowing the progression of CKD and improving renal and cardiovascular outcomes.
- Dosage: The usual starting dose is 10 mg once daily, which may be adjusted based on renal function and individual patient response.
- Administration: Take the tablet orally, with or without food, at the same time each day.
Common side effects may include:
- Hyperkalemia (elevated potassium levels)
- Hypotension (low blood pressure)
- Renal impairment
- Electrolyte Monitoring: Regular monitoring of serum potassium levels is essential, especially during treatment initiation and dose adjustments.
- Caution in Renal Impairment: Use with caution in patients with moderate to severe renal impairment.
- Hypotension Risk: Monitor blood pressure, particularly in patients on other antihypertensive medications.
- Hypersensitivity: Known allergies to finerenone or any components of the formulation.
- Severe Hyperkalemia: Contraindicated in patients with significantly elevated potassium levels.
Finerenone may interact with:
- Potassium-Sparing Diuretics: Increased risk of hyperkalemia.
- Certain Antihypertensives: Monitor for additive effects on blood pressure.
- Store Kerendia at room temperature, away from moisture and light. Keep out of reach of children.
- Educate patients on the importance of adhering to the prescribed regimen and attending regular follow-up appointments for monitoring.
- Advise them to report any symptoms of hyperkalemia (e.g., muscle weakness, irregular heartbeat) or signs of hypotension (e.g., dizziness, fainting).
- Encourage a balanced diet with limited potassium intake, if advised by a healthcare provider.
Kerendia (Finerenone 10 mg Tablet) is a vital medication for managing chronic kidney disease in patients with type 2 diabetes. Proper monitoring and patient education are crucial for maximizing therapeutic benefits while minimizing risks. Always consult a healthcare provider for personalized advice and guidance.
Rivaroxaban Rpigat 15mg Tablets
Product Brochure
| Strength | 15 mg |
| Dosage/Strength | 15 mg |
| Brand | Rpigat |
| Pack Size | 30 tablets |
| Packaging Size | 10 tablets in 1 strip |
| Composition (Salt) | Rivaroxaban 15mg |
| Brand Name | Rpigat 15mg |
| Manufacturer | Natco Pharma Ltd |
| Treatment | Treatment and prevention of Blood clots |
Overview
Rpigat contains rivaroxaban, an oral anticoagulant used to reduce the risk of thromboembolic events, such as blood clots and stroke, in certain medical conditions.
- Venous Thromboembolism (VTE): Treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE).
- Atrial Fibrillation: Reduction of the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
- Post-Surgical Patients: Prevention of VTE in patients undergoing hip or knee replacement surgery.
- Factor Xa Inhibition: Rivaroxaban selectively inhibits Factor Xa, an important enzyme in the coagulation cascade, which decreases thrombin production and inhibits clot formation.
- Dosage: The typical dose is 15 mg once daily for specific indications, such as the treatment of DVT or PE. Always follow the prescribing healthcare provider’s instructions for dosing based on the specific condition being treated.
- Administration: Take the tablet with food to enhance absorption. Swallow the tablet whole; do not crush or chew.
Common side effects may include:
- Bleeding (e.g., nosebleeds, bleeding gums, unusual bruising)
- Gastrointestinal symptoms (e.g., nausea, abdominal pain)
- Dizziness or headache
- Bleeding Risk: Increased risk of bleeding; monitor for signs of bleeding and report any unusual symptoms to a healthcare provider.
- Kidney Function: Use with caution in patients with renal impairment; dosage adjustments may be necessary.
- Surgery and Invasive Procedures: Discontinue rivaroxaban before surgery as directed by a healthcare provider to minimize bleeding risk.
- Hypersensitivity: Known allergies to rivaroxaban or any components of the formulation.
- Active Bleeding: Contraindicated in patients with active bleeding conditions (e.g., gastrointestinal bleeding, intracranial hemorrhage).
Rivaroxaban may interact with:
- Anticoagulants: Increased bleeding risk when used with other anticoagulants or antiplatelet medications.
- CYP3A4 Inhibitors/Inducers: Certain drugs may affect rivaroxaban metabolism, necessitating careful monitoring and possible dosage adjustments.
- Store Rpigat at room temperature, away from moisture and light. Keep out of reach of children.
- Educate patients on the importance of adherence to the prescribed regimen and the need for regular follow-ups.
- Advise them to report any signs of bleeding, such as unusual bruising, blood in urine or stool, or prolonged bleeding from cuts.
- Discuss the importance of informing healthcare providers about rivaroxaban use prior to any surgical or dental procedures.
Rpigat (Rivaroxaban 15 mg Tablets) is an effective anticoagulant for managing and preventing thromboembolic events. Proper monitoring, adherence to dosage instructions, and patient education are crucial for optimizing treatment outcomes while minimizing risks. Always consult a healthcare provider for personalized advice and guidance.
Rivaroxoban Rpigat 20mg Tablets
Product Brochure
| Strength | 20 mg |
| Dosage/Strength | 20 mg |
| Brand | Rpigat |
| Pack Size | 30 tablets |
| Packaging Size | 3*10 tablets |
| Composition (Salt) | Rivaroxoban Tablets |
| Brand Name | Rpigat 20 mg |
| Manufacturer | Natco |
| Treatment | Treatment and avoidance of Blood clumps |
Overview
Rpigat contains rivaroxaban, an oral anticoagulant used to prevent and treat thromboembolic disorders, including deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as to reduce the risk of stroke in patients with non-valvular atrial fibrillation.
- Treatment of DVT and PE: Used for the treatment of DVT and PE, including prevention of recurrence after initial therapy.
- Atrial Fibrillation: Reduces the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
- Post-Surgical Patients: Prevention of venous thromboembolism in patients undergoing hip or knee replacement surgery.
- Factor Xa Inhibition: Rivaroxaban selectively inhibits Factor Xa, an important component in the coagulation cascade, which leads to a decrease in thrombin generation and clot formation.
- Dosage: The typical dosage for the treatment of DVT or PE is 20 mg once daily. For stroke prevention in atrial fibrillation, the usual dose is also 20 mg once daily.
- Administration: Take the tablet with food to enhance absorption. Swallow the tablet whole; do not crush or chew.
Common side effects may include:
- Bleeding (e.g., easy bruising, nosebleeds)
- Gastrointestinal symptoms (e.g., nausea, abdominal pain)
- Headache or dizziness
- Bleeding Risk: There is an increased risk of bleeding; monitor for signs of bleeding and report any unusual symptoms.
- Renal Function: Use with caution in patients with renal impairment; dosage adjustments may be required.
- Surgery and Procedures: Discontinue rivaroxaban prior to surgery or invasive procedures as directed to minimize bleeding risk.
- Hypersensitivity: Known allergies to rivaroxaban or any components of the formulation.
- Active Bleeding: Contraindicated in patients with active bleeding conditions (e.g., gastrointestinal bleeding, intracranial hemorrhage).
Rivaroxaban may interact with:
- Anticoagulants and Antiplatelet Drugs: Increased risk of bleeding when used with other anticoagulants or antiplatelet medications.
- CYP3A4 Inhibitors and Inducers: Certain medications may affect the metabolism of rivaroxaban, requiring close monitoring and possible dosage adjustments.
- Store Rpigat at room temperature, away from moisture and light. Keep out of reach of children.
- Educate patients about the importance of adherence to the prescribed regimen and the need for regular follow-up appointments.
- Advise them to report any signs of bleeding, such as unusual bruising, blood in urine or stool, or prolonged bleeding from cuts.
- Discuss potential drug interactions and the importance of informing healthcare providers about all medications being taken.
Rpigat (Rivaroxaban 20 mg Tablets) is an important anticoagulant for managing thromboembolic disorders and preventing strokes in atrial fibrillation patients. Adherence to dosing instructions, monitoring for side effects, and patient education are critical for optimizing treatment outcomes. Always consult a healthcare provider for personalized advice and guidance.
Distoside Praziquantel 600mg Tablets
Product Brochure
| Strength | 600 mg |
| Pack Size | 4 Tablets |
| Brand | Distoside |
| Packaging Size | 2X4 Tablets |
| Composition | Praziquantel 600 mg |
| Brand Name | Distoside 600 mg |
| Manufactured By | Chandra Bhagat Pharma |
| Treatment | Parasitic Worm Infections |
Distoside is a brand of Praziquantel, an antiparasitic medication used primarily for treating infections caused by flatworms (trematodes and cestodes). It is particularly effective against schistosomiasis and other helminth infections.
Indications for UseDistoside is indicated for:
- Schistosomiasis: A parasitic disease caused by Schistosoma worms, which can affect various organs.
- Liver Fluke Infections: Effective against Fasciola hepatica and other liver flukes.
- Cestode Infections: Treatment for certain types of tapeworm infections.
Praziquantel works by:
- Disrupting the Parasite’s Cell Membrane: It alters the permeability of the cell membrane, leading to paralysis and death of the parasite.
- Enhancing Immune Response: It helps the immune system recognize and eliminate the parasites.
- Dosage: The standard dose varies depending on the type of infection. It is usually given as a single dose or in divided doses over a few days.
- Administration: Tablets are taken orally with water. They can be taken with or without food, but taking them with food may help reduce gastrointestinal side effects.
Distoside is contraindicated in:
- Hypersensitivity: Known allergies to Praziquantel or any of its components.
- Severe Liver Dysfunction: Caution is advised in patients with liver problems.
- Myelosuppression: Rarely, it may cause bone marrow suppression; monitoring may be required.
- CNS Effects: In cases of high parasite load, the treatment may cause increased CNS reactions as the parasites die.
Common side effects may include:
- Nausea and vomiting
- Dizziness
- Abdominal discomfort
- Headache
- Fatigue
Serious side effects are rare but can include:
- Severe allergic reactions (anaphylaxis)
- Neurological symptoms in cases of heavy infections
Praziquantel may interact with other medications, especially those affecting liver enzymes. Patients should inform their healthcare provider about all medications they are taking.
Storage InstructionsStore Distoside at room temperature, away from moisture and light. Follow specific storage guidelines on the product label.
Patient Counseling Information- Report Side Effects: Advise patients to notify their healthcare provider of any unusual reactions or symptoms.
- Adherence to Dosage: Emphasize the importance of completing the treatment as prescribed.
- Follow-Up: Discuss the need for follow-up evaluations to ensure the infection has been cleared.
Distoside (Praziquantel) 600mg Tablets are an effective treatment for various parasitic infections. Proper usage, monitoring, and patient education are essential for optimizing treatment outcomes and minimizing side effects. Always consult a healthcare professional for personalized advice and treatment plans.
Obeticholic Ocanat 5mg Tablets
Product Brochure
| Obeticholic Acid Strength | 5 mg |
| Strength | 5 mg |
| Indication | Primary Biliary Cholangitis |
| Dose Form | Tablet |
| Packaging Size | 10*10 Tablets |
| Brand Name | Ocanat 5 mg |
| Composition | Obeticholic Acide 5 mg |
| Manufactured By | Natco |
| Treatment | Primary biliary cirrhosis |
Ocanat contains Obeticholic Acid, a medication primarily used to treat liver diseases, particularly primary biliary cholangitis (PBC). It is a bile acid analog that helps improve liver function.
Indications for UseOcanat is indicated for:
- Primary Biliary Cholangitis (PBC): Used in adults to improve liver function and slow disease progression, often in combination with other therapies.
Obeticholic Acid works by:
- Activating FXR: It selectively binds to and activates the farnesoid X receptor (FXR), which regulates bile acid homeostasis and improves liver function.
- Reducing Bile Acid Synthesis: It decreases the production of bile acids in the liver, leading to reduced inflammation and fibrosis in liver tissues.
- Dosage: The usual starting dose is 5 mg once daily, which may be adjusted based on patient response and tolerability.
- Administration: Taken orally, with or without food. Consistency in how it is taken (with or without food) is important for maintaining stable drug levels.
Ocanat is contraindicated in:
- Hypersensitivity: Known allergies to Obeticholic Acid or any components of the formulation.
- Severe Liver Disease: Not recommended for patients with advanced liver disease (Child-Pugh Class C).
- Liver Function Monitoring: Regular monitoring of liver function tests is essential to assess treatment response and detect any potential adverse effects.
- Fatigue and Pruritus: Patients may experience fatigue and itching; these symptoms should be reported to a healthcare provider.
Common side effects may include:
- Fatigue
- Pruritus (itching)
- Abdominal pain
- Nausea
Serious adverse effects are rare but can include:
- Hepatic decompensation in patients with underlying liver disease
- Severe allergic reactions
Obeticholic Acid may interact with other medications that affect liver enzymes or bile acid metabolism. It’s important to inform healthcare providers about all medications being taken.
Storage InstructionsStore Ocanat at room temperature, away from moisture and light. Follow any specific storage guidelines provided on the product label.
Patient Counseling Information- Report Side Effects: Advise patients to notify their healthcare provider of any unusual symptoms, especially severe fatigue or itching.
- Regular Monitoring: Emphasize the importance of regular liver function tests and follow-up appointments.
Ocanat (Obeticholic Acid) 5 mg Tablets are an effective treatment option for managing primary biliary cholangitis. Proper usage, monitoring, and patient education are crucial for optimizing treatment outcomes and minimizing risks. Always consult a healthcare professional for personalized advice and management plans.
Desifer 400 Mg Tablet
Product Brochure
| Strength | 400 mg |
| Form | Tablet |
| Brand | Desifer |
| Packaging Size | 30 Tablets |
| Composition | Deferasirox 400mg |
| Brand Name | Desifer 400mg |
| Manufacturer | Natco |
| Treatment | Iron overload |
Active Ingredient: Deferasirox
Uses:
Desifer is primarily used to treat chronic iron overload in patients who have received multiple blood transfusions. It is often prescribed for individuals with conditions such as thalassemia or sickle cell disease, where excess iron can accumulate and lead to organ damage.
Deferasirox works as a chelating agent, binding to excess iron in the body. This complex is then excreted through feces, helping to reduce iron levels and prevent related complications.
Dosage and Administration:- Typical Dosage: The usual starting dose is based on the patient's body weight and iron levels. A healthcare provider will determine the appropriate dosage.
- Administration: Taken orally, typically once daily. It can be taken with or without food. Swallow the tablet whole, without chewing.
- Hypersensitivity: Avoid in patients with known allergies to Deferasirox or its components.
- Severe Renal Impairment: Caution is advised in patients with kidney issues.
- Monitoring: Regular monitoring of liver and kidney function, as well as blood counts, is often required.
- Drug Interactions: Inform healthcare providers about all medications being taken to avoid interactions.
- Gastrointestinal disturbances (nausea, diarrhea, abdominal pain)
- Rash
- Increased liver enzymes
- Severe allergic reactions (e.g., rash, swelling)
- Liver dysfunction
- Kidney problems
Store at room temperature, away from moisture and light. Follow any specific storage instructions on the product label.
Patient Counseling Information:- Report Side Effects: Advise patients to notify their healthcare provider of any unusual symptoms or side effects.
- Adherence: Stress the importance of taking the medication as prescribed and attending regular follow-up appointments.
Desifer 400 mg Tablets are crucial for managing iron overload in patients requiring regular blood transfusions. Proper adherence to the treatment plan and monitoring are essential for safety and effectiveness. Always consult a healthcare professional for personalized guidance regarding this medication.
Sodium Bicarbonate Sodiheal Tablets (Sodiheal 500mg Tablets)
Product Brochure
| Strength | 500 mg |
| Use | Antacid |
| Strip Pack Size | 10 tablets |
| Pack Size | 10*10 Tablets |
| Brand | Sodiheal 500 mg Tablets |
| Composition | Sodium Bicarbonate 500 mg |
| Manufactured By | Healing Pharma India Pvt Ltd |
| Treatment | Indigestion |
Active Ingredient: Sodium Bicarbonate
Uses:
Sodiheal tablets are primarily used to:
- Treat metabolic acidosis (a condition where there is too much acid in the body fluids).
- Alleviate symptoms of heartburn and indigestion by neutralizing stomach acid.
- Help maintain the body's pH balance in various medical conditions.
Sodium Bicarbonate acts as an antacid by neutralizing excess stomach acid. It also serves as a buffering agent, helping to maintain pH balance in the body, particularly in conditions of acidosis.
Dosage and Administration:- Typical Dosage: The dosage will depend on the specific condition being treated and should be determined by a healthcare provider.
- Administration: Tablets are usually taken orally, and it’s important to follow the specific instructions regarding timing (e.g., after meals or as directed).
- Hypersensitivity: Avoid in patients with known allergies to Sodium Bicarbonate or its components.
- Severe Kidney Disease: Caution is advised, as Sodium Bicarbonate can affect electrolyte balance.
- Fluid Retention: Use cautiously in patients with conditions that may be exacerbated by sodium retention (e.g., heart failure, hypertension).
- Electrolyte Imbalance: Regular monitoring of electrolytes may be required, especially in long-term use.
- Gastrointestinal discomfort (e.g., gas, bloating)
- Nausea
- Diarrhea
- Metabolic alkalosis (too much bicarbonate in the blood)
- Severe allergic reactions (e.g., rash, swelling)
Store Sodiheal tablets at room temperature, away from moisture and light. Follow any specific storage guidelines provided with the product.
Patient Counseling Information:- Report Side Effects: Advise patients to notify their healthcare provider of any unusual symptoms or side effects.
- Adherence: Stress the importance of taking the medication as prescribed and following dietary recommendations.
Sodiheal (Sodium Bicarbonate) 500 mg Tablets are effective for managing conditions related to acid-base imbalance and gastrointestinal symptoms. Proper use and adherence to the treatment plan are crucial for achieving the desired outcomes. Always consult a healthcare professional for personalized advice regarding this medication.
Imatinib Imatirel 400mg Tablet
Product Brochure
| Strength | 400 mg |
| Dose/Strength | 400 mg |
| Brand | Imatirel |
| Tablets per Pack | 10 Tablets |
| Packaging Size | 10 Tablets |
| Packaging Type | Stripe |
| Manufacturer | Reliance Life Sciences |
| Brand Name | Imatirel 400mg |
| Treatment | Cancer |
Imatirel is a tyrosine kinase inhibitor primarily used to treat specific types of cancers. It targets the BCR-ABL fusion protein, which is instrumental in the growth of certain cancer cells. This medication is essential for patients diagnosed with conditions like chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST).
IndicationsImatirel is indicated for the treatment of:
- Chronic Myeloid Leukemia (CML): Effective in the chronic phase.
- Acute Lymphoblastic Leukemia (ALL): Particularly in cases involving the Philadelphia chromosome.
- Gastrointestinal Stromal Tumors (GIST): For patients with unresectable or metastatic tumors.
- Dermatofibrosarcoma Protuberans (DFSP): And other tumors expressing PDGFR.
Imatinib works by inhibiting the BCR-ABL fusion protein, blocking the signaling pathways that promote cancer cell survival and proliferation. This targeted action helps in controlling tumor growth.
Dosage and Administration- Standard Dosage: The typical adult dosage is 400 mg once daily. Dosages may vary based on the cancer type and patient response.
- Administration: Imatirel can be taken with or without food. If gastrointestinal upset occurs, taking it with food may alleviate discomfort. Swallow the tablet whole with water for best results.
Imatirel should not be used in:
- Patients with hypersensitivity to imatinib or any of its components.
- Individuals with severe liver impairment.
- Fluid Retention: Monitor for signs of edema or congestive heart failure.
- Liver Function: Regular liver function tests are recommended to detect potential liver enzyme elevations.
- Myelosuppression: Blood counts should be monitored regularly due to the risk of neutropenia, anemia, or thrombocytopenia.
- Drug Interactions: Inform your healthcare provider about all medications you are taking, as imatinib can interact with various drugs.
Common Side Effects include:
- Nausea and vomiting
- Diarrhea
- Fatigue
- Edema (swelling)
- Skin rash
Serious Side Effects may involve:
- Severe allergic reactions
- Liver toxicity (elevated liver enzymes)
- Heart failure
- Myelosuppression (low blood counts)
Imatinib may interact with other medications, particularly those that affect liver enzymes. Always inform your healthcare provider about any other drugs or supplements you are using.
Storage InstructionsStore Imatirel at room temperature (20°C to 25°C or 68°F to 77°F) in a dry place, away from moisture and light.
Patient Counseling Information- Advise patients to report any signs of fluid retention, severe fatigue, or signs of infection.
- Discuss the importance of regular blood tests to monitor liver function and blood counts.
- Inform patients about potential side effects and provide guidance on when to seek medical attention.
Imatirel (Imatinib) is a vital medication for managing specific cancers, requiring careful monitoring for side effects and interactions. Always consult a healthcare professional for personalized medical advice and treatment plans.
Olumiant Baricitinib 2 mg Tablets
Product Brochure
| Strength | 2 mg |
| Composition | Baricitinib 2 mg |
| Strength / Dose | 2 mg |
| Brand | Olumiant |
| Packaging Size | 7 Tablets |
| Brand Name | Olumiant |
| Manufacturer By | Eli Lilly and Company India Pvt Ltd |
| Treatment | Rheumatoid arthritis |
Overview:
Olumiant 2mg Tablet contains Baricitinib, a Janus kinase (JAK) inhibitor used in the treatment of moderate to severe rheumatoid arthritis (RA) in adults who have not responded well to other therapies like methotrexate. By inhibiting JAK1 and JAK2, Baricitinib reduces the activity of immune cells responsible for inflammation, helping manage symptoms such as pain, swelling, and joint damage.
Indications:
Olumiant 2mg Tablet is primarily indicated for:
- Rheumatoid Arthritis (RA): To treat moderate to severe RA in adults who have failed or cannot tolerate other disease-modifying antirheumatic drugs (DMARDs).
- Atopic Dermatitis: It may also be used for atopic dermatitis in certain patients based on a healthcare provider's discretion.
Mechanism of Action:
Baricitinib works by inhibiting Janus kinases (JAKs), which are enzymes involved in the inflammatory process. By blocking these enzymes, it reduces the production of pro-inflammatory cytokines, helping to control symptoms and prevent further joint damage in patients with RA.
Dosage and Administration:
- Recommended Dose: 2mg once daily, with or without food. The dose may be increased to 4mg based on the patient's condition and tolerance.
- Administration: Take Orally with water. Do not chew, crush, or break the tablet.
- Adjustments: Adjust the dosage for renal or liver impairment.
Side Effects:
Common side effects include:
- Nausea, headache, high blood pressure, and upper respiratory infections.
- Fatigue, diarrhea, and acne.
Serious side effects may include:
- Infections (e.g., tuberculosis, fungal infections).
- Blood clots and cardiovascular risks (e.g., DVT, PE).
- Liver damage: Regular monitoring is essential.
Precautions:
- Infections: Screen for active infections before starting therapy.
- Pregnancy: Avoid use during pregnancy.
- Liver and Kidney Health: Monitor liver and kidney function regularly.
Storage:
Store at room temperature (20°C to 25°C), away from moisture and heat.
Conclusion:
Olumiant 2mg Tablet (Baricitinib) is an effective treatment for moderate to severe rheumatoid arthritis in adults who have not responded to traditional DMARDs. Careful monitoring for infections, blood clots, liver function, and cardiovascular health is essential for safe use.
Entecavir 1 mg ( Zhevavir 1 mg Tablets)
Product Brochure
| Strength | 1 mg |
| Packaging Size | 10 tablets |
| Brand | Zhevavir 1 mg |
| Pack Size | 1*10 Tablet |
| Composition | Entecavir 1 mg |
| Treatment | Hronic (Long-Term) Hepatitis B Infection |
| Manufacturer By | Sunrise Farma |
Zhevavir (Entecavir) 1 mg Tablets
Overview: Zhevavir is a brand name for entecavir, an antiviral medication used primarily in the treatment of chronic hepatitis B virus (HBV) infection. It is effective in reducing viral load and improving liver function in patients with HBV.
Indications:
- Chronic Hepatitis B Infection: Indicated for the treatment of chronic hepatitis B virus infection in adults and children over the age of 2 years who have evidence of active viral replication and elevated liver enzymes.
Mechanism of Action: Entecavir is a nucleoside analogue that inhibits HBV replication by incorporating into the viral DNA, thus preventing the virus from multiplying. It specifically targets the reverse transcriptase enzyme involved in the viral replication process.
Dosage and Administration:
- Recommended Dose: The typical dose for adults is 0.5 mg daily for patients who are treatment-naive and 1 mg daily for those who have been previously treated with other antiviral medications.
- Administration: Take the tablet orally, with or without food. It is important to take it at the same time each day to maintain consistent levels in the bloodstream.
Side Effects: Common side effects may include:
- Headache
- Fatigue
- Dizziness
- Nausea
- Potential for lactic acidosis (rare but serious)
Warnings and Precautions:
- Liver Function: Monitor liver function tests regularly, as discontinuation of entecavir may result in an exacerbation of hepatitis.
- Lactic Acidosis: Caution is advised in patients with liver disease or those at risk for lactic acidosis.
- Renal Function: Monitor renal function, especially in patients with pre-existing kidney conditions.
Contraindications:
- Hypersensitivity to entecavir or any components of the formulation.
- Severe renal impairment may require dose adjustment.
Drug Interactions: Entecavir may interact with other medications that affect kidney function or are metabolized by the liver. Patients should inform their healthcare provider about all medications they are taking.
Storage Instructions: Store at room temperature, away from moisture and light. Keep out of reach of children.
Patient Counseling Information:
- Advise patients to take the medication as prescribed and to maintain adherence to the treatment regimen.
- Discuss the importance of regular follow-up appointments for monitoring liver function and viral load.
- Instruct patients to report any unusual side effects, especially symptoms of liver dysfunction or signs of lactic acidosis (e.g., unusual fatigue, muscle pain).
Zhevavir (Entecavir) 1 mg Tablets are an effective treatment option for managing chronic hepatitis B infection. Adherence to dosing, regular monitoring for side effects, and patient education are crucial for achieving optimal treatment outcomes. Always consult a healthcare provider for personalized treatment recommendations.
Zonaxid Nitazoxanide 500mg Tablets
Product Brochure
| Strength | 500 mg |
| Pack Size | 6 tablets |
| Brand | Zonaxid 500mg |
| Manufacturer | Macleods Pharmaceuticals Pvt Ltd |
| Packaging Size | 6 Tablets in 1 Strip |
| Composition | Nitazoxanide 500 mg |
| Usage/Applicat | Treatment of Diarrhea, Worm infections |
Introduction: Zonaxid contains Nitazoxanide, an antiparasitic and antiviral medication used to treat a variety of infections. It is effective against certain gastrointestinal infections caused by protozoa and helminths, as well as some viral infections.
Indications for Use:
- Protozoal Infections: Used for the treatment of infections such as giardiasis (caused by Giardia lamblia) and cryptosporidiosis (caused by Cryptosporidium parvum).
- Viral Infections: Indicated for the treatment of viral gastroenteritis, particularly in immunocompromised patients.
Mechanism of Action: Nitazoxanide works by inhibiting the anaerobic energy metabolism of protozoa and certain viruses, leading to their death. It disrupts the pyruvate-ferredoxin oxidoreductase (PFOR) enzyme-dependent electron transport, which is essential for energy production in these organisms.
Dosage and Administration:
- Dosage: The typical adult dose is 500 mg taken orally twice daily. Dosing may vary based on the specific infection and patient factors.
- Administration: Can be taken with or without food. It’s advisable to take it consistently at the same times each day.
Contraindications:
- Hypersensitivity: Known allergies to Nitazoxanide or any components of the formulation.
- Pregnancy and Breastfeeding: Use during pregnancy should be approached with caution; consult a healthcare provider.
Warnings and Precautions:
- Liver Function: Caution is advised in patients with liver disease; liver function tests may be recommended.
- Drug Interactions: Inform healthcare providers of all medications being taken, as Nitazoxanide may interact with other drugs.
Common Side Effects:
- Nausea
- Abdominal pain
- Diarrhea
- Headache
Serious Side Effects:
- Allergic reactions (rash, itching, swelling)
- Severe gastrointestinal symptoms
Storage Instructions: Store Zonaxid at room temperature, away from moisture and light. Follow any specific storage guidelines provided on the product label.
Patient Counseling Information:
- Report Side Effects: Advise patients to notify their healthcare provider of any unusual symptoms or side effects.
- Complete the Course: Emphasize the importance of completing the full course of treatment as prescribed.
Conclusion: Zonaxid (Nitazoxanide) 500 mg Tablets are an effective treatment option for various gastrointestinal infections. Proper usage and adherence to the treatment plan are essential for achieving the best outcomes. Always consult a healthcare professional for personalized advice and guidance regarding this medication.
1mg Baraclude Entecavir Tablets
Product Brochure
| Strength | 1 mg |
| Packaging Size | 30 Tablets in 1 Bottle |
| Brand | Baraclude |
| Composition | Entecavir 1mg |
| Brand Name | Baraclude |
| Prescription/Non prescription | Prescription |
| Manufacturer | BMS India Pvt Ltd |
| Usages | Chronic hepatitis B virus infection |
| Also gives | Third Party Manufacturing |
| Country of Origin | Made in India |
| Packaging Type | Bottles |
Description:
Entecavir is an antiviral medication that is primarily used to treat chronic hepatitis B virus (HBV) infection. It works by inhibiting the replication of the virus, thereby reducing the amount of HBV in the body and improving liver function.
Indications:
Entecavir is indicated for the treatment of:
- Chronic Hepatitis B Virus Infection: Effective in adults and children aged 2 years and older with active liver disease.
Dosage and Administration:
- Dosage: The recommended dose for adults is typically 0.5 mg once daily for those without previous treatment, and 1 mg once daily for those who have previously been treated with other antiviral therapies. Pediatric dosing may vary based on weight.
- Administration: Taken orally, with or without food. It is important to take entecavir at the same time each day to maintain consistent blood levels.
Common Side Effects:
- Fatigue
- Headache
- Dizziness
- Nausea
- Diarrhea
Precautions:
- Liver Function Monitoring: Regular liver function tests are essential, as reactivation of hepatitis B can occur after stopping treatment.
- Renal Impairment: Dose adjustments may be necessary for patients with kidney problems.
- Not Recommended During Pregnancy: Consult a healthcare provider for risk assessment and alternative options.
Conclusion:
Entecavir (Baraclude 1 mg) is an antiviral medication used to treat chronic hepatitis B infection. Treatment should be closely monitored by a healthcare professional to ensure safety and effectiveness, with regular assessments of liver function and potential side effects.
Emeset Ondansetron 4mg Tablet
Product Brochure
| Strength | 4 mg |
| Dose/Strength | 4 mg |
| Pack size | 10 tablets |
| Brand | Emeset |
| Packaging Size | 10*5*10 Tablets |
| Composition | Ondansetron 4 mg |
| Brand Name | Emeset-4 mg |
| Manufacturer | Cipla |
| Treatment | Nausea |
Emeset contains Ondansetron, an antiemetic medication used primarily to prevent nausea and vomiting caused by chemotherapy, radiation therapy, or surgery.
Indications for UseEmeset is indicated for:
- Chemotherapy-Induced Nausea and Vomiting: Prevents and treats nausea and vomiting associated with cancer treatments.
- Radiation Therapy: Used to prevent nausea and vomiting in patients undergoing radiation treatment.
- Postoperative Nausea and Vomiting: Helps manage nausea and vomiting after surgery.
Ondansetron works by:
- Blocking Serotonin Receptors: Specifically, it is a selective antagonist of the 5-HT3 serotonin receptor. By blocking these receptors in the gastrointestinal tract and central nervous system, it reduces the likelihood of nausea and vomiting.
- Dosage: The typical dose for adults is 4 mg, which can be taken 30 minutes before chemotherapy or surgery. Additional doses may be given as needed, depending on the specific treatment regimen.
- Administration: Taken orally, with or without food. Tablets should be swallowed whole with water.
Emeset is contraindicated in:
- Hypersensitivity: Known allergies to Ondansetron or any components of the formulation.
- Electrolyte Imbalance: Use with caution in patients with electrolyte imbalances, especially low potassium or magnesium levels.
- Heart Conditions: Caution is advised in patients with a history of QT prolongation or other heart conditions, as Ondansetron may affect heart rhythm.
Common side effects may include:
- Headache
- Dizziness
- Constipation
- Fatigue
Serious adverse effects are rare but can include:
- Allergic reactions (rash, itching, swelling)
- Severe headache
- Changes in heart rhythm (QT prolongation)
Ondansetron may interact with other medications that affect heart rhythm or those that influence serotonin levels. Always inform healthcare providers about all medications being taken.
Storage InstructionsStore Emeset at room temperature, away from moisture and light. Follow any specific storage guidelines on the product label.
Patient Counseling Information- Report Side Effects: Advise patients to notify their healthcare provider of any unusual symptoms or side effects, particularly if experiencing chest pain or heart palpitations.
- Adherence to Dosage: Encourage patients to take the medication as prescribed for optimal effectiveness, especially around chemotherapy or surgery.
Emeset (Ondansetron) 4 mg Tablets are an effective option for managing nausea and vomiting associated with chemotherapy, radiation, and postoperative recovery. Proper use, monitoring, and patient education are essential for maximizing therapeutic outcomes. Always consult a healthcare professional for personalized advice and treatment plans.
Baraclude Entecavir 0.5 mg Tablets
Product Brochure
| Strength | 0.5 mg |
| Packaging Size | 30 Tablets in 1 Box |
| Composition | Entecavir 0.5 mg |
| Brand | Baraclude 0.5 mg |
| Manufactured By | BMS India Pvt Ltd |
| Usages/Application | Chronic Hepatitis B Virus (HBV) Infectio |
Baraclude (Entecavir) 0.5 mg Tablets
Overview: Baraclude is a brand name for entecavir, an antiviral medication used primarily for the treatment of chronic hepatitis B virus (HBV) infection. It helps reduce viral load and improve liver function in affected individuals.
Indications:
- Chronic Hepatitis B Infection: Indicated for the treatment of chronic hepatitis B virus infection in adults and pediatric patients over 2 years of age who have evidence of active viral replication.
Mechanism of Action: Entecavir is a nucleoside analogue that inhibits the replication of HBV by acting as a substrate for the reverse transcriptase enzyme, preventing the conversion of viral RNA into DNA. This inhibits viral replication and reduces the viral load.
Dosage and Administration:
- Recommended Dose: The typical dose for adults who are treatment-naive is 0.5 mg once daily. For patients who have previously received treatment with other antiviral medications, the dose may be increased to 1 mg once daily.
- Administration: Take the tablet orally, with or without food. It’s important to take it at the same time each day for consistent results.
Side Effects: Common side effects may include:
- Headache
- Fatigue
- Dizziness
- Nausea
- Potential for lactic acidosis (rare but serious)
Warnings and Precautions:
- Liver Function: Regular monitoring of liver function tests is important, as discontinuation of entecavir may result in an exacerbation of hepatitis.
- Lactic Acidosis: Caution is advised in patients with liver disease or those at risk for lactic acidosis.
- Renal Function: Monitor renal function, particularly in patients with pre-existing kidney conditions.
Contraindications:
- Hypersensitivity to entecavir or any components of the formulation.
- Severe renal impairment may require dose adjustment.
Drug Interactions: Entecavir may interact with other medications, particularly those affecting kidney function or liver metabolism. Patients should inform their healthcare provider about all medications they are taking.
Storage Instructions: Store at room temperature, away from moisture and light. Keep out of reach of children.
Patient Counseling Information:
- Advise patients to take the medication as prescribed and to adhere to the treatment regimen.
- Discuss the importance of regular follow-up appointments for monitoring liver function and viral load.
- Instruct patients to report any unusual side effects, especially symptoms of liver dysfunction or signs of lactic acidosis (e.g., unusual fatigue, muscle pain).
Baraclude (Entecavir) 0.5 mg Tablets are an effective option for managing chronic hepatitis B infection. Adherence to dosing, regular monitoring for side effects, and patient education are essential for achieving optimal treatment outcomes. Always consult a healthcare provider for personalized treatment recommendations.
Levocetirizine Tablets (Levocetzime 10mg Tablets)
Product Brochure
| Strength | 10 mg |
| Packaging Size | 10 tablets in 1 strip |
| Composition | Levocetirizine 10mg |
| Brand | Levocetzime 10mg Tablets |
| Manufactured By | Healing Pharma India Pvt Ltd |
| Usage/Application | Treatment of Allergic conditions |
Overview
Levocetzime contains levocetirizine, an antihistamine used primarily to relieve allergy symptoms. It is an enantiomer of cetirizine and is effective in treating allergic rhinitis and chronic urticaria (hives).
- Allergic Rhinitis: Relief of symptoms such as sneezing, runny or itchy nose, and itchy or watery eyes due to allergies.
- Chronic Urticaria: Treatment of itching and rash associated with chronic hives.
- Antihistamine Activity: Levocetirizine selectively inhibits peripheral H1 receptors, reducing the effects of histamine, a substance in the body that causes allergic symptoms. This action helps alleviate allergic responses.
- Dosage: The usual recommended dose for adults and children over 12 years is 10 mg once daily. For children aged 6 to 11 years, a lower dose may be recommended.
- Administration: Take the tablet orally with or without food, preferably at the same time each day.
Common side effects may include:
- Drowsiness
- Fatigue
- Dry mouth
- Headache
- Drowsiness: May cause drowsiness; caution is advised when driving or operating heavy machinery.
- Kidney Function: Use with caution in patients with renal impairment; dosage adjustments may be necessary.
- Alcohol Interaction: Avoid alcohol, as it can enhance drowsiness.
- Hypersensitivity: Known allergies to levocetirizine, cetirizine, or any components of the formulation.
Levocetirizine may interact with:
- Central Nervous System Depressants: Increased sedation when used with other CNS depressants (e.g., alcohol, sedatives).
- Store Levocetzime at room temperature, away from moisture and light. Keep out of reach of children.
- Educate patients about the potential for drowsiness and the need to avoid activities requiring alertness until they know how the medication affects them.
- Advise them to take the medication consistently and report any severe side effects or allergic reactions.
Levocetzime (Levocetirizine 10 mg Tablets) is an effective antihistamine for managing allergy symptoms and chronic urticaria. Proper usage and patient education are essential for optimizing therapeutic benefits and minimizing risks. Always consult a healthcare provider for personalized advice and guidance.
Finerenone Kerendia 20mg Tablet
Product Brochure
| Strength | 20 mg |
| Packaging Type | Strips |
| Packaging Size | 14 tablets in 1 box |
| Brand | Kerendia 20 mg |
| Manufactured By | Bayer Zydus Pharma Pvt Ltd |
| Composition | Finerenone Film Coated Tablets 20 mg |
| Treatment | Chronic kidney disease |
Overview
Kerendia contains finerenone, a non-steroidal mineralocorticoid receptor antagonist (MRA) designed to manage chronic kidney disease (CKD) in patients with type 2 diabetes.
- Chronic Kidney Disease: Used to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular events in adults with CKD associated with type 2 diabetes.
- Mineralocorticoid Receptor Antagonism: Finerenone selectively inhibits mineralocorticoid receptors, leading to reduced inflammation and fibrosis in the kidneys, which can slow CKD progression and improve renal and cardiovascular outcomes.
- Dosage: The typical starting dose is 10 mg once daily, which may be increased to 20 mg once daily based on the patient's renal function and response to treatment.
- Administration: Take the tablet orally, with or without food, preferably at the same time each day.
Common side effects may include:
- Hyperkalemia (high potassium levels)
- Hypotension (low blood pressure)
- Renal impairment
- Electrolyte Monitoring: Regular monitoring of serum potassium levels is essential, especially during treatment initiation and dose adjustments.
- Caution in Renal Impairment: Use with caution in patients with moderate to severe renal impairment.
- Hypotension Risk: Monitor blood pressure, particularly in patients on other antihypertensive medications.
- Hypersensitivity: Known allergies to finerenone or any components of the formulation.
- Severe Hyperkalemia: Contraindicated in patients with significantly elevated potassium levels.
Finerenone may interact with:
- Potassium-Sparing Diuretics: Increased risk of hyperkalemia.
- Certain Antihypertensives: Monitor for additive effects on blood pressure.
- Store Kerendia at room temperature, away from moisture and light. Keep out of reach of children.
- Educate patients on the importance of adhering to the prescribed regimen and attending regular follow-up appointments for monitoring.
- Advise them to report any symptoms of hyperkalemia (e.g., muscle weakness, irregular heartbeat) or signs of hypotension (e.g., dizziness, fainting).
- Encourage a balanced diet with limited potassium intake, if advised by a healthcare provider.
Kerendia (Finerenone 20 mg Tablet) is an important medication for managing chronic kidney disease in patients with type 2 diabetes. Proper monitoring and patient education are essential for maximizing therapeutic benefits while minimizing risks. Always consult a healthcare provider for personalized advice and guidance.
Cilostaheal Cilostazol 50mg Tablets
Product Brochure
| Strength | 50 mg |
| Pack Size | 1*10 Tablet |
| Composition | Cilostazol 50mg |
| Brand | Cilostaheal 50 mg Tablets |
| Manufactured By | Healing Pharma India Pvt Ltd |
| Treatment | Intermittent Claudication |
Active Ingredient: Cilostazol
Uses:
Cilostaheal is primarily used for:
- Intermittent Claudication: To improve walking distance in patients with this condition, which is caused by poor blood flow to the legs.
Cilostazol works by inhibiting phosphodiesterase type 3 (PDE3), which leads to increased levels of cyclic AMP (cAMP) in platelets and blood vessels. This results in vasodilation (widening of blood vessels) and inhibition of platelet aggregation, improving blood flow and reducing symptoms of claudication.
Dosage and Administration:- Typical Dosage: The usual dose is 100 mg taken orally twice daily. However, it may be initiated at 50 mg twice daily in some cases.
- Administration: Take the tablets at least half an hour before or two hours after meals for optimal absorption.
- Hypersensitivity: Avoid in individuals with known allergies to Cilostazol or any components of the formulation.
- Heart Failure: Not recommended in patients with congestive heart failure (CHF) of any severity.
- Bleeding Risk: Caution in patients with bleeding disorders or those taking anticoagulant or antiplatelet medications.
- Liver Function: Monitor liver function, as Cilostazol is metabolized in the liver.
- Drug Interactions: Inform healthcare providers about all medications being taken, as Cilostazol can interact with other drugs.
- Headache
- Diarrhea
- Dizziness
- Palpitations
- Flushing
- Severe headache
- Abnormal bleeding or bruising
- Symptoms of heart failure (e.g., shortness of breath, swelling)
Store Cilostaheal tablets at room temperature, away from moisture and light. Follow any specific storage guidelines provided with the product.
Patient Counseling Information:- Report Side Effects: Advise patients to notify their healthcare provider of any unusual symptoms or side effects, particularly severe headaches or signs of bleeding.
- Adherence: Emphasize the importance of taking the medication as prescribed and not missing doses.
- Lifestyle Modifications: Encourage patients to engage in supervised exercise programs to improve walking ability.
Cilostaheal (Cilostazol) 50 mg Tablets are effective in improving walking distance for patients with intermittent claudication. Proper adherence to the treatment regimen and monitoring for side effects are essential for safety and effectiveness. Always consult a healthcare professional for personalized guidance regarding this medication.
Immulina Pidotimod 800mg Tablets
Product Brochure
| Strength | 800 mg |
| Packaging Size | 1 box of 10 tablets |
| Composition | Pidotimod 800 mg |
| Brand Name | Immulina 800mg |
| Manufactured By | Mr. Reddy's |
| Usage/Application | Diseases of respiratory tract |
Active Ingredient: Pidotimod
Uses:
Immulina is primarily used for:
- Immune System Support: It is indicated for the prevention and treatment of recurrent respiratory infections, particularly in children.
- Adjunct Therapy: Often used alongside conventional treatments for infections to enhance immune response.
Pidotimod acts as an immunomodulator. It stimulates the immune system by enhancing the activity of macrophages and T-cells, promoting a more effective immune response against pathogens. This helps in reducing the frequency and severity of infections.
Dosage and Administration:- Typical Dosage: The usual dose for adults and children may vary, but commonly it is taken as 800 mg once daily. The specific dosage should be determined by a healthcare provider based on the condition being treated.
- Administration: Can be taken with or without food. It’s advisable to take the tablet whole with water.
- Hypersensitivity: Avoid in individuals with known allergies to Pidotimod or any components of the formulation.
- Pregnancy and Breastfeeding: Consult a healthcare provider before use during pregnancy or while breastfeeding.
- Autoimmune Disorders: Use with caution in patients with autoimmune conditions.
- Nausea
- Diarrhea
- Abdominal pain
- Headache
- Mild allergic reactions (e.g., rash)
- Severe allergic reactions (e.g., difficulty breathing, swelling of the face or throat)
- Signs of infection (fever, persistent cough)
Store Immulina tablets at room temperature, away from moisture and light. Follow any specific storage guidelines provided with the product.
Patient Counseling Information:- Report Side Effects: Advise patients to notify their healthcare provider of any unusual symptoms or side effects.
- Adherence: Emphasize the importance of taking the medication as prescribed and completing the full course of treatment, especially for recurrent infections.
Immulina (Pidotimod) 800 mg Tablets are effective for enhancing immune response and reducing the frequency of respiratory infections. Proper adherence to the treatment regimen and monitoring for side effects are crucial for safety and effectiveness. Always consult a healthcare professional for personalized guidance regarding this medication.
Sorafenib (Soratib 200mg Tablet)
Product Brochure
| Packaging Size | 30 Tablets |
| Strength | 200 mg |
| Form | Tablet |
| Prescription/Non prescription | Prescription |
| Brand | Soratib |
| Composition | Sorafenib |
Sorafenib (Soratib 200mg Tablet)
Overview:
Soratib (Sorafenib 200mg Tablet) is an oral chemotherapy medication used to treat certain types of cancer. It is primarily indicated for the treatment of advanced renal cell carcinoma (RCC), hepatocellular carcinoma (HCC), and differentiated thyroid carcinoma. Sorafenib is a multi-kinase inhibitor that works by blocking the angiogenesis (growth of new blood vessels) and the signaling pathways involved in tumor growth and spread. By inhibiting multiple tyrosine kinases, Sorafenib helps slow tumor progression and reduces cancer cell proliferation.
Indications:
Soratib 200mg Tablets are indicated for:
- Renal Cell Carcinoma (RCC): In patients with advanced or metastatic RCC.
- Hepatocellular Carcinoma (HCC): For patients with advanced liver cancer.
- Differentiated Thyroid Cancer: For patients with progressive disease after radioactive iodine treatment.
Mechanism of Action:
Sorafenib inhibits multiple kinases, including those involved in angiogenesis (VEGF receptors), as well as other kinases related to tumor cell proliferation (Raf, B-RAF, VEGFR, PDGFR, c-kit). This dual action disrupts both the growth of blood vessels that supply the tumor and the signaling pathways that control tumor cell survival and division. Sorafenib helps reduce tumor growth by cutting off its blood supply and limiting the proliferation of cancer cells.
Dosage and Administration:
- Recommended Dose: The usual dose is 200 mg twice daily, taken with or without food.
- Administration: Swallow the tablet whole with a glass of water.
- Missed Dose: If a dose is missed, take it as soon as possible, but if it is close to the next dose, skip the missed dose. Do not take two doses at once.
Side Effects:
Common side effects include:
- Fatigue, diarrhea, rash, hand-foot syndrome, and hypertension.
Serious side effects may include: - Liver toxicity: Regular liver function tests are needed.
- Hemorrhage: Risk of bleeding, especially in patients with HCC.
- Cardiovascular issues: Hypertension and ischemic events.
Precautions:
- Liver Disease: Caution in patients with liver impairment as Sorafenib can cause liver toxicity.
- Hypertension: Monitor blood pressure regularly, especially in patients with HCC.
- Pregnancy: Contraindicated in pregnancy due to potential fetal harm.
Storage:
Store Soratib 200mg Tablets at room temperature (20°C to 25°C), away from moisture and light. Keep out of reach of children.
Conclusion:
Soratib 200mg Tablet (Sorafenib) is an effective treatment for several types of advanced cancers. By inhibiting tumor growth and angiogenesis, it helps slow cancer progression. Regular monitoring for side effects, especially liver function and blood pressure, is crucial for safe and effective use.
Pirfenidone Pulmofib 267 mg Tablets
Product Brochure
| Strength | 267 mg |
| Packaging Size | 10X10 Tablets |
| Brand | Pulmofib 267 mg |
| Manufactured By | Msn Laboratories Pvt Ltd |
| Composition | Pirfenidone 267 mg |
| Treatment | Idiopathic Pulmonary Fibrosis |
| Medicine brand | Pulmofib |
| Medicine form | Tablet |
| Medicine name | pirfenidone tablets ip |
| Medicine strength | 267 mg |
| Packaging size | 10 x 10 tablets |
| Packaging type | Box |
| Salt composition | Pirfenidone |
View More